Log in or create a free account to read this content
Gain free access to this article, as well as selected content from this journal and more on nature.com
or
References
Chan CK, Abraham P, Sarraf D . High-dose ranibizumab therapy for vascularized pigment epithelial detachment. Eye 2012; 26 (6): 882–885.
Sykakis E, Malandrakis M, Pushpoth S, Browning A, Gupta R, Talks J . Intravitreal ranibizumab and intravitreal triamcinolone with PDT for the treatment of retinal angiomatous proliferation. A retrospective comparative study. AMD Clinical Trials III, ; 2 May 2011; Newcastle Upon Tyne, UK (ARVO abstract 2011: 1660/A55).
Macular Photocoagulation Study Group. Subfoveal neovascular lesions in age-related macular degeneration. Guidelines for evaluation and treatment in the macular photocoagulation study group. Arch Ophthalmol 1991; 109 (9): 1242–1257.
Barbazetto I, Burdan A, Bressler NM, Bressler SB, Haynes L, Kapetanios AD et al. Photodynamic therapy of subfoveal choroidal neovascularization with verteporfin: fluorescein angiographic guidelines for evaluation and treatment—TAP and VIP report No. 2. Arch Ophthalmol 2003; 121 (9): 1253–1268.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
J Talks has received travel expenses and or attended advisory boards for Allergan, Novartis, Bayer, Alamera Sciences. The remaining authors declare no conflict of interest.
Rights and permissions
About this article
Cite this article
Talks, S., Gupta, R. & Browning, A. Alternative diagnosis for cases presented as vPED treated with high-dose ranibizumab. Eye 26, 1599–1600 (2012). https://doi.org/10.1038/eye.2012.207
Published:
Issue date:
DOI: https://doi.org/10.1038/eye.2012.207
This article is cited by
-
Response to Talks et al
Eye (2012)